NASDAQ:PHAR charts & data provided by TradingView

Latest Insights on PHAR

The market is dying to COVID-19 fear, but Great Stuff is killing it… (Phrasing? Do we not do “phrasing” anymore?) While Wall Street Falls, Great Stuff Goes Alpha
by Joseph Hargett February 28, 2020 2020 Financial Crisis, Great Stuff
Friday Four Play: The “Get a Leg up” Edition It’s no secret … I like being right. But to reference a line from The Matrix: “Not like this. Not like this.” So far this week, the Dow is off 3,200 points … and counting. Wall Street’s favorite barometer is down roughly 13% from its February […]
coronavirus fears and stock market increases This Play Is Set to Soar — With or Without the Coronavirus
by Clint Lee February 26, 2020 2020 Financial Crisis, Big Picture. Big Profits., Investment Opportunities, U.S. Economy
[3-minute read] Demographic trends will deliver massive long-term profits.
Whatever your market plans, remember that Great Stuff is never gonna give you up, never gonna let you down … we’ll never run around or desert you! China’s Potential Doom; INO’s Biotech Boom
by Joseph Hargett February 14, 2020 2020 Financial Crisis, Great Stuff
Friday Four Play: The “Never Gonna Give You Up” Edition Happy Valentine’s Day, dear readers! I don’t have chocolates, roses or even dinner reservations (I know, I’m a horrible date today). But I do have market data and stock gains for Great Stuff readers. Let’s start with the good news. U.S. retail sales rose for […]
For Seasoned Traders — 3 More Ways to Get Happy Rich This Year!
by Kristen Barrett February 8, 2020 American Investor Today, Diversified Investments
This week, we share four trading strategies that seasoned traders can follow to get “happy rich” in 2020. Strategy No. 1: Don’t lose money trying to guess earnings. Chad Shoop will show you how to profit from earnings after companies report. Strategy No. 2: Forget bonds and dividends for income. Chad Shoop has an income strategy that boasts a 97% win rate! Strategy No. 3: Natural resources such as oil and copper are volatile. But Matt Badiali and John Ross have a system to profit from the boom-bust cycle.
abbvie stock Profit From AbbVie’s Struggles Today
by Chad Shoop February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

Share This